FIGS Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Movement Adient ADNT Q1 2026 Earnings EPS Surprise Drives DoubleDigit Stock Rally BioLineRx Ltd BLRX Q3 2024 Earnings Loss Per Share of 007 on No Revenue Shares Surge 9 Immunovant IMVT Q1 2026 Earnings NarrowerThanExpected Loss but EPS Miss Highlights RD Spending KLAR Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Response CVU Q1 2021 Earnings EPS Surges Past Estimates But Stock Declines on Revenue Concerns iBio Inc IBIO Q1 2026 Earnings EPS Miss on Higher RD Spend Stock Rises Despite No Revenue TScan Therapeutics Q1 2026 Earnings Narrowing Loss Despite EPS Miss Stock Gains on Pipeline Progress Mereo BioPharma Group plc MREO Q1 2026 Earnings NarrowerThanExpected Loss Drives Modest Stock Uplift LULU Q1 2026 Earnings EPS Surprise Shows Resilience Amid Tepid Market Response RenovoRx Inc RNXT Q1 2026 Earnings Wider Loss Per Share Amid PreRevenue ClinicalStage Operations SHBI Q1 2026 Earnings EPS Surges Past Estimates by 111 on Solid Operational Performance XFOR Q1 2026 Earnings EPS Beats Estimates Despite Continued PreRevenue Status Stock Declines CME Q1 2026 Earnings EPS Slightly Misses Consensus as Shares Edge Higher RGTI Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Quantum Computing Development BHP Q1 2026 Earnings EPS Miss Weighs on Sentiment as Commodity Headwinds Persist LIND Q1 2026 Earnings Stellar EPS Surprise of 452 Drives Stock Rally GTN Q1 2026 Earnings EPS Misses Estimates as Media Headwinds Persist UTI Q1 2026 Earnings EPS Misses Estimates but Stock Climbs on Positive Indicators